You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Agranulocytosis

Showing 1 - 25 of 227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reporting of Antibody-Drug Conjugate Associated Sepsis-related

Completed
  • Sepsis (SMQ)
  • +2 more
  • Antibody-Drug Conjugate
  • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
  • Changsha, Hunan, China
    Central South University
Jun 19, 2022

Fungal Infection Trial in China (Caspofungin)

Completed
  • Fungal Infection
  • Fuzhou, Fujian, China
  • +5 more
Jul 6, 2021

Untreated Graves' Hyperthyroidism Avoiding Thionamide Drugs With

Completed
  • Graves Disease
  • Potassium Iodide
  • (no location specified)
Dec 24, 2020

Natural History Study for BEN

Completed
  • Neutropenia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 29, 2020

    Schizophrenia Trial in Catonsville (Clozapine)

    Completed
    Has Results
    • Schizophrenia
    • Catonsville, Maryland
      Maryland Psychiatric Research Center
    Jan 11, 2023

    Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 13, 2022

    Bipolar Disorder Trial in Gdansk (Clozapine)

    Enrolling by invitation
    • Bipolar Disorder
    • Gdańsk, Pomorskie, Poland
      Department of Psychiatry, Medical University of Gdańsk
    Aug 21, 2023

    Infections Trial in Ghent (device, diagnostic test, other)

    Not yet recruiting
    • Infections
    • Prediction of plasma concentration of piperacillin-tazobactam or meropenem
    • +2 more
    • Ghent, Belgium
      University Hospital, Ghent
    Sep 4, 2023

    Assess Adverse Events When Subcutaneous Risankizumab Injection

    Withdrawn
    • Psoriasis
    • (no location specified)
    Dec 8, 2022

    Schizophrenia and Related Disorders, Early Treatment-Resistance Trial in Worldwide (Clozapine, Second-line Antipsychotics

    Not yet recruiting
    • Schizophrenia and Related Disorders
    • Early Treatment-Resistance
    • Clozapine
    • Second-line Antipsychotics (treatment as usual)
    • Innsbruck, Austria
    • +12 more
    Jul 27, 2023

    Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

    Recruiting
    • Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • "3+7"
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 29, 2023

    Malaria Trial in Nanoro (Sulfadoxine pyrimethamine, Amodiaquine)

    Recruiting
    • Malaria
    • Nanoro, Burkina Faso
      Unité de Recherche Clinique de Nanoro
    Jul 26, 2022

    Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • Best-Available Therapy(BAT) Regimen
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Oct 10, 2023

    Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

    Recruiting
    • Acute Monocytic Leukemia
    • Newly Diagnosed
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Oct 3, 2022

    Atypical Antipsychotics inGeriatric Population: What is Role of

    Recruiting
    • Neutropenia
      • Strasbourg, France
        Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
      Oct 27, 2023

      Preeclampsia Trial in Peoria (Aspirin 162 mg)

      Recruiting
      • Preeclampsia
      • Aspirin 162 mg
      • Peoria, Illinois
        UnityPoint Clinic Family Medicine
      Jan 22, 2022

      HIV, Inflammatory Markers, Colchicine Adverse Reaction Trial in Ratchathewi (Low-dose colchicine, Placebo)

      Recruiting
      • HIV Infections
      • +2 more
      • Low-dose colchicine
      • Placebo
      • Ratchathewi, ฺBangkok, Thailand
        Angsana Phuphuakrat
      Dec 20, 2021

      Patient Acceptance of Health Care Trial in Shanghai (Methimazole(MMI))

      Recruiting
      • Patient Acceptance of Health Care
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiaotong University School of Medicine
      Sep 4, 2021

      Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML Trial in Suzhou (CAHAG regimen, Placebo regimen)

      Recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • CAHAG regimen
      • Placebo regimen
      • Suzhou, Jiangsu, China
        The First Affliated Hospital of Soochow University
      Oct 10, 2021

      Stomach Ulcer Trial in Tokyo (Rebamipide)

      Completed
      Has Results
      • Stomach Ulcer
      • Tokyo, Japan
        Otsuka Pharmaceutical Co., Ltd.
      May 11, 2021

      Migraine Abortive Treatment

      Recruiting
      • Migraine Disorders
      • Haifa, Israel
        Bnai Zion Medical Center
      Sep 9, 2021

      Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

      Recruiting
      Has Results
      • Multiple Sclerosis
      • Interferon beta-1a
      • +3 more
      • Birmingham, Alabama
      • +106 more
      Jan 13, 2023

      Migraine Disorders Trial (Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care)

      Completed
      Has Results
      • Migraine Disorders
      • Rizatriptan 5 mg
      • +2 more
      • (no location specified)
      Feb 1, 2022

      Eltrombopag Trial in Assiut (Eltrombopag)

      Completed
      • Eltrombopag
      • Assiut, Egypt
        Facility of medicine
      Jan 13, 2022

      MDD, Treatment Resistant Depression Trial in Worldwide (Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine HCl)

      Not yet recruiting
      • Major Depressive Disorder
      • Treatment Resistant Depression
      • Esketamine Nasal Product
      • +3 more
      • Innsbruck, Austria
      • +12 more
      Jul 25, 2023